Apogem Capital LLC Shattuck Labs, Inc. Transaction History

Apogem Capital LLC

  • $303 Million
  • Q4 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$2.6 - $5.52 $7,051 - $14,970
2,712 Added 3.57%
78,757 $213,000
Q2 2022

Aug 15, 2022
BUY
$2.7 - $4.59 $46,456 - $78,975
17,206 Added 29.24%
76,045 $309,000
Q1 2022

May 16, 2022
BUY
$4.22 - $8.89 $165,820 - $349,323
39,294 Added 201.04%
58,839 $251,000
Q4 2021

Feb 14, 2022
BUY
$8.36 - $21.08 $54,808 - $138,200
6,556 Added 50.47%
19,545 $166,000
Q3 2021

Nov 15, 2021
BUY
$17.57 - $28.95 $228,216 - $376,031
12,989 New
12,989 $265,000

Others Institutions Holding STTK

# of Institutions
80
Shares Held
28.8M
Call Options Held
300
Put Options Held
1.2K
View Full List

About Shattuck Labs, Inc.

STTK Quotes by TradingView
  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $46.6M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Apogem Capital LLC Portfolio

Follow Apogem Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apogem Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email